The Valley Desk

Clinical trial reportNeuro-oncologyPublished

Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Neuro-oncology
Published
Subject terms
Humans; Lymphoma; Central Nervous System Neoplasms; Procarbazine; Vincristine; Methotrexate; Cytarabine; Antineoplastic Combined Chemotherapy Protocols; Prognosis; Immunotherapy; Cranial Irradiation; Survival Rate
PubMed ID
41189315
PubMed Central ID
PMC12904153
Added to directory
Source checked

Report a correction or request removal